Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/9/2019
China Built 158 Internet Hospitals and Telemedicine Platforms in 19 Pr...
5/9/2019
Chinese Health Expenditure Projected to Reach 9.1% of GDP by 2035
5/9/2019
China Cashes In on the Cannabis Boom
5/9/2019
Chinese Bioethicists Call for 'Reboot' of Biomedical Regulation after ...
5/9/2019
Allergan Launches $14.7M Innovation Center with China Optimism
5/9/2019
Alipay's Mutual Aid Platform Xiang Hu Bao Now Covers Chinese Senior Ci...
5/9/2019
Innovent-Lilly Partnership Announces Positive Clinical Results of Ritu...
5/9/2019
Helsinn and Mundipharma Launch Cancer Care Drug ALOXI IV in China
5/9/2019
InnoCare PharmaTech Plans to $250M IPO in Hong Kong
5/9/2019
Recent Chinese Study links Diabetes and Numerous Cancers
5/9/2019
Amerigen Announces USFDA Approval for Generic Penicillamine
5/9/2019
Progressive Reforms Shifting the Cancer Medicine Landscape in China
5/9/2019
Alembic Pharma Forms Chinese Joint Venture
5/8/2019
Chinese Pharma Billionaire Paid $6.5M to Get Daughter into Stanford
5/8/2019
Research Point Global and WuXi CDS to Rebrand as WuXi Clinical
5/8/2019
Merck's Successful First Quarter Largely Driven by China Growth
5/8/2019
CDE Publicizes Four More Drug Applications To Be Granted Priority Revi...
5/8/2019
NMPA Announces Package Insert Revision of Bromocriptine Mesylate Table...
5/6/2019
China's Conditional Approval of Bayer's Acquisition of Monsanto: Lesso...
5/6/2019
Sun Pharma Eyes China Expansion with A Local Partner
5/6/2019
Pre-revenue Tot Biopharma Files for Listing in Hong Kong
5/6/2019
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Cli...
5/6/2019
Bayer's Pharma Sales in Q1/2019 Benefited from Volume Growth of Some D...
5/5/2019
China Pilots Program to Regulate Medical Services by Dynamic Means
5/5/2019
China Promote IT Application in Community Healthcare Facilities
5/3/2019
Immunomedics and Everest Medicines Announce License Agreement for Saci...
5/3/2019
Chinese Hospitals Set to Sell Experimental Cell Therapies
5/3/2019
Some Big Pharma Cos Raise 2019 Outlook Driven by China Prospects and N...
5/3/2019
Kangmei's $4bn Accounting Error Highlights China Risk
5/1/2019
IQVIA Report Provides A Brids-Eye-View of Chinese Drug Market for NCDs
Page:
228
/
720
Total number of articles:
21572
:
[First]
[<<]
[226]
[227]
[228]
[229]
[230]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit